Inhibition of IKKβ in enterocytes exacerbates sepsis-induced intestinal injury and worsens mortality

Jessica A Dominguez1, Alexandr J Samocha, Zhe Liang

  • 11Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO. 2Department of Surgery, Washington University School of Medicine, St. Louis, MO. 3Emory Center for Critical Care and Department of Surgery, Emory Healthcare and Emory University School of Medicine, Atlanta, GA. 4Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.

Critical Care Medicine
|August 14, 2013
PubMed
Abstract

Insights

Enterocyte-specific Nuclear factor-κB (NF-κB) plays a protective role in sepsis, mitigating intestinal damage and reducing mortality. Ablating NF-κB in intestinal cells worsens sepsis outcomes, highlighting its importance in host defense.

Area of Science:

  • Gastroenterology
  • Immunology
  • Molecular Biology

Background:

  • Nuclear factor-κB (NF-κB) is a key regulator of cell survival and inflammation.
  • Understanding the role of specific NF-κB pathways in sepsis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of enterocyte-specific NF-κB in sepsis.
  • To determine the effects of selectively ablating IkB kinase (IKK) in intestinal cells on sepsis outcomes.

Main Methods:

  • Prospective, randomized controlled study in university medical center animal laboratories.
  • Mice with enterocyte-specific NF-κB deficiency (Vil-Cre/Ikkβ) and wild-type controls underwent cecal ligation and puncture (sepsis model) or sham surgery.
  • Evaluated intestinal morphology, apoptosis, permeability, cytokine profiles, bacterial load, and survival rates.

Main Results:

  • Septic mice exhibited villus atrophy, increased apoptosis, and hyperpermeability, which were significantly exacerbated in Vil-Cre/Ikkβ mice.
  • Enterocyte-specific NF-κB deficiency led to higher levels of IL-10 and MCP-1.
  • Mortality was significantly higher in septic Vil-Cre/Ikkβ mice (80%) compared to wild-type mice (47%).
  • Anti-TNF therapy improved intestinal integrity and survival in both groups.

Conclusions:

  • Enterocyte-specific NF-κB plays a beneficial role in sepsis.
  • It partially prevents sepsis-induced apoptosis and hyperpermeability, thereby reducing mortality.
  • Targeting NF-κB in intestinal cells may offer therapeutic potential for sepsis management.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...